Middle East and Africa Infusion (Elastomeric) Pumps Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2033

Middle East and Africa Infusion (Elastomeric) Pumps Market Size

• The Middle East and Africa Infusion (Elastomeric) Pumps Market size was valued at USD 30.50 billion in 2025 and is expected to reach USD 63.03 billion by 2033, at a CAGR of 9.50% during the forecast period
• The market growth is largely fueled by the increasing demand for portable and cost-effective drug delivery systems, along with advancements in infusion technologies, leading to improved patient convenience and treatment efficiency across healthcare settings
• Furthermore, rising prevalence of chronic diseases, growing adoption of home-based healthcare, and increasing need for continuous and controlled drug delivery are establishing elastomeric infusion pumps as an essential component of modern medical care. These converging factors are accelerating the uptake of Infusion (Elastomeric) Pumps solutions, thereby significantly boosting the industry's growth

Middle East and Africa Infusion (Elastomeric) Pumps Market Analysis

• Infusion (elastomeric) pumps, which are portable medical devices used for continuous drug delivery, are increasingly vital in modern healthcare due to their ability to provide accurate, controlled, and convenient administration of medications in both hospital and home care settings
• The escalating demand for infusion (elastomeric) pumps is primarily fueled by the rising prevalence of chronic diseases, increasing adoption of home-based healthcare, and growing need for cost-effective and user-friendly drug delivery system
• Saudi Arabia dominated the Middle East and Africa Infusion (Elastomeric) Pumps Market with the largest revenue share of approximately 33.1% in 2025, characterized by improving healthcare infrastructure, increasing adoption of advanced medical devices, and strong government initiatives to enhance healthcare services, with the country witnessing steady growth driven by rising demand for home infusion therapies
• U.A.E. is expected to be the fastest growing country in the Middle East and Africa Infusion (Elastomeric) Pumps Market during the forecast period, with a projected CAGR of around 8.9%, due to increasing healthcare expenditure, growing awareness of home-based care, rising prevalence of chronic diseases, and expanding access to advanced medical technologies
• The elastomeric infusion pumps segment dominated the largest market revenue share of 62.4% in 2025, driven by their widespread use in continuous drug delivery for outpatient and homecare settings

Report Scope and Middle East and Africa Infusion (Elastomeric) Pumps Market Segmentation

Middle East and Africa Infusion (Elastomeric) Pumps Market Trends

“Advancements in Portable Drug Delivery and Home-Based Care Solutions”

• A significant and accelerating trend in the Middle East and Africa Infusion (Elastomeric) Pumps Market is the growing adoption of portable and user-friendly drug delivery systems that enable efficient administration of medications outside traditional hospital settings
• These devices are increasingly being used for chemotherapy, antibiotics, and pain management, improving patient comfort and reducing hospital stays
• For instance, elastomeric infusion pumps are widely utilized in home healthcare settings for continuous delivery of antibiotics in patients with chronic infections, allowing treatment without prolonged hospitalization and improving overall patient convenience
• In addition, technological improvements in pump design, such as enhanced flow rate accuracy and reduced device complexity, are making these systems more reliable and easier for both healthcare providers and patients to use
• The rising preference for outpatient and ambulatory care services across the region is further accelerating the demand for elastomeric pumps, particularly in managing long-term therapies
• Furthermore, increasing investments in healthcare infrastructure and the expansion of home healthcare services in countries across the Middle East and Africa are supporting the widespread adoption of these devices

Middle East and Africa Infusion (Elastomeric) Pumps Market Dynamics

Driver

“Increasing Demand for Home Healthcare and Chronic Disease Management”

• The growing prevalence of chronic diseases such as cancer, diabetes, and infectious diseases is a key driver for the Middle East and Africa Infusion (Elastomeric) Pumps Market in the Middle East and Africa. These conditions often require continuous drug administration, making elastomeric pumps a preferred solution due to their convenience and efficiency
• For instance, elastomeric pumps are increasingly used for chemotherapy drug delivery in oncology patients, enabling continuous infusion therapy while allowing patients to remain at home or in outpatient settings
• In addition, the rising demand for home healthcare services, driven by cost-effectiveness and patient comfort, is significantly boosting the adoption of portable infusion devices across the region.
• Government initiatives aimed at improving healthcare access and expanding medical services in rural and underserved areas are further supporting market growth
• Moreover, increasing awareness among healthcare professionals regarding the benefits of elastomeric pumps, including reduced infection risk and improved patient compliance, is contributing to their growing utilization

Restraint/Challenge

“Limited Healthcare Infrastructure and Device Cost Constraints”

• One of the major challenges in the Middle East and Africa Infusion (Elastomeric) Pumps Market is the limited availability of advanced healthcare infrastructure in certain parts of the Middle East and Africa, which can restrict the adoption of specialized medical devices
• For instance, in some low-income regions, hospitals and clinics may lack adequate training and resources to effectively deploy and manage elastomeric infusion systems, limiting their widespread use
• In addition, the relatively high cost of elastomeric pumps and associated consumables can act as a barrier for healthcare providers and patients, particularly in price-sensitive markets
• Lack of awareness and training among patients and caregivers regarding the proper use of these devices may also hinder adoption and lead to suboptimal outcomes
• Furthermore, regulatory and supply chain challenges, including inconsistent product availability and import dependencies, can impact market growth and accessibility across the region

Middle East and Africa Infusion (Elastomeric) Pumps Market Scope

The market is segmented on the basis of product type, route of administration, application, end user, and distribution channel.

• By Product Type

On the basis of product type, the Middle East and Africa Infusion (Elastomeric) Pumps Market is segmented into elastomeric infusion pumps, and accessories and consumables. The elastomeric infusion pumps segment dominated the largest market revenue share of 62.4% in 2025, driven by their widespread use in continuous drug delivery for outpatient and homecare settings. These pumps are highly preferred due to their portability, ease of use, and cost-effectiveness compared to electronic infusion systems. Increasing prevalence of chronic diseases such as cancer and infections supports demand for continuous infusion therapies. Growing preference for ambulatory care and home-based treatment further boosts adoption. Elastomeric pumps do not require batteries or electricity, making them suitable for remote and resource-limited settings. Rising healthcare infrastructure development across the Middle East and Africa enhances accessibility. Increasing awareness among healthcare providers about the benefits of elastomeric systems further drives usage. Expansion of pain management and chemotherapy treatments supports growth. Technological advancements improving accuracy and safety enhance reliability. These factors collectively ensure the dominance of the elastomeric infusion pumps segment.

The accessories and consumables segment is expected to witness the fastest CAGR of 9.8% from 2026 to 2033, driven by the recurring demand for components such as tubing, connectors, and reservoirs required for infusion therapy. Increasing number of infusion procedures directly boosts consumption of these products. Growth in hospital admissions and outpatient treatments further supports demand. Rising adoption of elastomeric pumps increases the need for compatible consumables. Continuous replacement requirements ensure steady revenue generation. Expansion of healthcare facilities across emerging economies strengthens market penetration. Increasing focus on infection control and single-use components boosts demand. Technological advancements in consumable design improve safety and efficiency. Growing awareness regarding hygiene and patient safety further accelerates adoption. These factors position accessories and consumables as the fastest-growing segment.

• By Route of Administration

On the basis of route of administration, the market is segmented into subcutaneous, intravenous (IV), intramuscular, and epidural. The intravenous (IV) segment held the largest market revenue share of 48.7% in 2025, driven by its widespread use in delivering fluids, antibiotics, chemotherapy, and pain management drugs. IV administration ensures rapid drug delivery and immediate therapeutic effect, making it highly preferred in critical care settings. Increasing number of surgical procedures supports demand for IV infusion systems. Rising prevalence of chronic diseases requiring long-term therapy further drives growth. Hospitals and clinics heavily rely on IV routes for accurate dosage control. Advancements in infusion technologies enhance safety and precision. Expansion of healthcare infrastructure in the region improves accessibility. Increasing adoption in emergency care strengthens usage. These factors collectively ensure the dominance of the intravenous segment.

The subcutaneous segment is expected to witness the fastest CAGR of 10.2% from 2026 to 2033, driven by growing preference for minimally invasive and home-based drug administration methods. Subcutaneous infusion allows slow and controlled drug delivery, making it suitable for chronic disease management. Increasing adoption in palliative care and pain management supports growth. Rising demand for patient-friendly treatment options further boosts adoption. Expansion of home healthcare services enhances accessibility. Technological advancements improve ease of use and comfort. Growing elderly population requiring long-term care strengthens demand. These factors position subcutaneous administration as the fastest-growing segment.

• By Application

On the basis of application, the market is segmented into antibiotic/antiviral therapy, pain management, chemotherapy, thalassemia treatment, diuretics treatment, long-term infusion treatment, and other applications. The pain management segment accounted for the largest market revenue share of 36.5% in 2025, driven by increasing prevalence of chronic pain conditions and post-surgical pain management requirements. Elastomeric pumps are widely used for continuous analgesic delivery, improving patient comfort and recovery outcomes. Rising number of surgical procedures further supports demand. Increasing awareness regarding effective pain control enhances adoption. Expansion of palliative care services strengthens growth. Growing geriatric population contributes to higher pain-related conditions. Technological advancements in infusion systems improve precision and safety. Increasing preference for outpatient pain management boosts usage. These factors ensure dominance of the pain management segment.

The chemotherapy segment is expected to witness the fastest CAGR of 11.4% from 2026 to 2033, driven by rising cancer incidence across the Middle East and Africa. Elastomeric pumps enable controlled and continuous drug delivery in oncology treatments. Increasing adoption of ambulatory chemotherapy supports growth. Expansion of oncology care centers enhances accessibility. Rising investment in cancer treatment infrastructure boosts demand. Growing awareness regarding advanced treatment options further accelerates adoption. Technological advancements improve drug delivery efficiency. These factors position chemotherapy as the fastest-growing application segment.

• By End User

On the basis of end user, the market is segmented into hospitals, homecare settings, ambulatory surgical centers, academic and research institutes, specialty clinics, and others. The hospitals segment dominated the largest market revenue share of 44.8% in 2025, driven by high patient inflow and availability of advanced healthcare infrastructure. Hospitals are primary centers for infusion therapy, especially for critical and surgical cases. Increasing number of hospital admissions supports demand for infusion pumps. Availability of skilled healthcare professionals ensures effective usage. Rising investments in hospital infrastructure across the region further boost growth. Increasing prevalence of chronic diseases drives demand for long-term treatments. Hospitals also facilitate complex therapies such as chemotherapy and IV infusions. Strong procurement capabilities ensure steady supply of devices. These factors collectively ensure the dominance of the hospitals segment.

The homecare settings segment is expected to witness the fastest CAGR of 10.9% from 2026 to 2033, driven by increasing preference for home-based treatment and reduced hospital stays. Elastomeric pumps are ideal for homecare due to their portability and ease of use. Rising healthcare costs encourage patients to opt for home treatment. Expansion of home healthcare services supports market growth. Increasing elderly population requiring continuous care further boosts demand. Technological advancements enhance usability and safety. Growing awareness regarding home-based therapies strengthens adoption. These factors position homecare settings as the fastest-growing segment.

• By Distribution Channel

On the basis of distribution channel, the market is segmented into direct tender, retail sales, online sales, and others. The direct tender segment held the largest market revenue share of 50.6% in 2025, driven by bulk procurement by hospitals and government healthcare institutions. Direct tenders ensure cost efficiency and long-term supply agreements. Increasing public healthcare investments across the region support procurement. Large-scale purchasing by hospitals enhances segment dominance. Strong supplier relationships ensure consistent product availability. Growing demand for infusion therapies further drives bulk procurement. These factors ensure dominance of the direct tender segment.

The online sales segment is expected to witness the fastest CAGR of 9.6% from 2026 to 2033, driven by increasing digitalization in healthcare procurement. Rising internet penetration supports online purchasing. Healthcare providers and smaller clinics prefer online platforms for convenience and accessibility. Expansion of e-commerce channels enhances product availability. Growing demand for quick and efficient procurement boosts adoption. Improved logistics and delivery systems support growth. Increasing awareness of digital platforms further accelerates usage. These factors position online sales as the fastest-growing distribution channel.

Middle East and Africa Infusion (Elastomeric) Pumps Market Regional Analysis

• The Middle East and Africa Infusion (Elastomeric) Pumps Market is projected to expand at a substantial CAGR throughout the forecast period, driven by rising prevalence of chronic diseases, increasing demand for home-based healthcare, and gradual improvement in healthcare infrastructure across the region
• Healthcare systems in the region are increasingly adopting portable and cost-effective drug delivery solutions to improve patient outcomes, particularly for long-term therapies such as antibiotics, chemotherapy, and pain management
• This growing adoption is further supported by increasing government investments in healthcare modernization, expansion of hospital facilities, and rising awareness regarding advanced infusion therapies, especially in urban healthcare centers

Saudi Arabia Middle East and Africa Infusion (Elastomeric) Pumps Market Insight

The Saudi Arabia Middle East and Africa Infusion (Elastomeric) Pumps Market dominated the region with the largest revenue share of approximately 33.1% in 2025, supported by strong government healthcare initiatives, rapid expansion of medical infrastructure, and increasing adoption of advanced medical technologies. The country is witnessing steady growth due to rising demand for home infusion therapies and hospital-based continuous drug delivery systems. In addition, increasing focus on improving chronic disease management and expanding access to quality healthcare services is further driving market growth in Saudi Arabia.

U.A.E. Middle East and Africa Infusion (Elastomeric) Pumps Market Insight

The U.A.E. Middle East and Africa Infusion (Elastomeric) Pumps Market is expected to be the fastest growing in the region during the forecast period, with a projected CAGR of around 8.9%, driven by rising healthcare expenditure, increasing prevalence of chronic diseases, and strong adoption of home healthcare solutions. The country’s advanced healthcare infrastructure and rapid integration of innovative medical technologies are further supporting market expansion. Moreover, government initiatives focused on improving patient care quality and expanding access to modern treatment options are accelerating growth in the U.A.E.

Middle East and Africa Infusion (Elastomeric) Pumps Market Share

The Infusion (Elastomeric) Pumps industry is primarily led by well-established companies, including:

• B. Braun SE (Germany)
• Baxter International Inc. (U.S.)
• Fresenius Kabi AG (Germany)
• Smiths Medical (U.K.)
• ICU Medical, Inc. (U.S.)
• Terumo Corporation (Japan)
• Nipro Corporation (Japan)
• BD (U.S.)
• JMS Co. Ltd. (Japan)
• Vygon SA (France)
• Avanos Medical, Inc. (U.S.)
• Moog Inc. (U.S.)
• Poly Medicure Ltd. (India)
• Micrel Medical Devices (Greece)
• Leventon S.A.U. (Spain)
• Eitan Medical (Israel)
• Epic Medical (Singapore)
• Halyard Health (U.S.)
• Fresenius SE & Co. KGaA (Germany)
• Angiplast Pvt. Ltd. (India)

Latest Developments in Middle East and Africa Infusion (Elastomeric) Pumps Market

• In June 2021, B. Braun Melsungen AG expanded its elastomeric infusion pump portfolio across key markets, strengthening its position in ambulatory infusion therapy and home healthcare applications. This expansion reflects growing demand for portable, non-electric infusion solutions in outpatient settings
• In September 2022, Fresenius Kabi announced the expansion of its infusion therapy product portfolio, including elastomeric pumps, to support increasing demand for safe and efficient drug delivery systems in hospitals and home care. This move highlights the company’s focus on enhancing infusion technologies and patient care outcomes
• In April 2023, ICU Medical, Inc. introduced advancements in its ambulatory infusion systems, including elastomeric pump solutions designed to improve accuracy and ease of use in continuous drug delivery. These developments support the shift toward outpatient and home-based infusion therapies
• In August 2024, Baxter International Inc. highlighted increased adoption of elastomeric infusion pumps within its advanced infusion systems portfolio, driven by rising demand for portable drug delivery solutions in pain management and chemotherapy. This reflects the growing importance of ambulatory infusion devices in modern healthcare
• In February 2025, industry reports indicated rising global demand for elastomeric infusion pumps due to increasing prevalence of chronic diseases and expanding home healthcare services. This trend underscores the shift toward cost-effective, patient-friendly infusion solutions outside traditional hospital settings
• In October 2025, ongoing product innovation in elastomeric pump design focused on improving flow rate accuracy, safety mechanisms, and user convenience, supporting broader adoption across oncology, antibiotic therapy, and pain management applications. This development highlights continuous technological advancement in the market

SKU-69430